These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 36875095)

  • 21. Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation.
    Sieber J; Daridon C; Fleischer SJ; Fleischer V; Hiepe F; Alexander T; Heine G; Burmester GR; Fillatreau S; Dörner T
    Arthritis Res Ther; 2014 Nov; 16(6):477. PubMed ID: 25385499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus.
    Umiker BR; Andersson S; Fernandez L; Korgaokar P; Larbi A; Pilichowska M; Weinkauf CC; Wortis HH; Kearney JF; Imanishi-Kari T
    Eur J Immunol; 2014 May; 44(5):1503-16. PubMed ID: 24500834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging roles of TLR7 and TLR9 in murine SLE.
    Santiago-Raber ML; Baudino L; Izui S
    J Autoimmun; 2009; 33(3-4):231-8. PubMed ID: 19846276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of TLR7 and TLR9 genes polymorphisms in Egyptian patients with systemic lupus erythematosus.
    Azab MM; Mostafa FM; Khalil M; Salama M; Abdelrahman AA; Ali AA
    Heliyon; 2022 Nov; 8(11):e11680. PubMed ID: 36439744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus.
    Yang Y; Wang C; Cheng P; Zhang X; Li X; Hu Y; Xu F; Hong F; Dong G; Xiong H
    Front Immunol; 2018; 9():2643. PubMed ID: 30498494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.
    Barrat FJ; Meeker T; Gregorio J; Chan JH; Uematsu S; Akira S; Chang B; Duramad O; Coffman RL
    J Exp Med; 2005 Oct; 202(8):1131-9. PubMed ID: 16230478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment.
    Celhar T; Fairhurst AM
    Front Pharmacol; 2014; 5():265. PubMed ID: 25538618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus-Associated Immune Complexes Activate Human Neutrophils in an FcγRIIA-Dependent but TLR-Independent Response.
    Bonegio RG; Lin JD; Beaudette-Zlatanova B; York MR; Menn-Josephy H; Yasuda K
    J Immunol; 2019 Feb; 202(3):675-683. PubMed ID: 30610165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyruvate Kinase M2 Contributes to TLR-Mediated Inflammation and Autoimmunity by Promoting Pyk2 Activation.
    Zhang X; Yang Y; Jing L; Zhai W; Zhang H; Ma Q; Li C; Yan F; Cheng D; Zhang J; Ning Z; Shi H; Wang C; Zhao M; Dai J; Li Z; Ming J; Yu M; Wang H; Cheng H; Xiong H; Dong G
    Front Immunol; 2021; 12():680068. PubMed ID: 34025679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of TLR7 increases CCND3 expression via the downregulation of miR-15b in B cells of systemic lupus erythematosus.
    Ren D; Liu F; Dong G; You M; Ji J; Huang Y; Hou Y; Fan H
    Cell Mol Immunol; 2016 Nov; 13(6):764-775. PubMed ID: 26144250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y
    Front Immunol; 2018; 9():1957. PubMed ID: 30210502
    [No Abstract]   [Full Text] [Related]  

  • 32. Phospholipase D4 as a signature of toll-like receptor 7 or 9 signaling is expressed on blastic T-bet + B cells in systemic lupus erythematosus.
    Yasaka K; Yamazaki T; Sato H; Shirai T; Cho M; Ishida K; Ito K; Tanaka T; Ogasawara K; Harigae H; Ishii T; Fujii H
    Arthritis Res Ther; 2023 Oct; 25(1):200. PubMed ID: 37840148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
    Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
    Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
    Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ
    Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus.
    Richez C; Blanco P; Rifkin I; Moreau JF; Schaeverbeke T
    Joint Bone Spine; 2011 Mar; 78(2):124-30. PubMed ID: 20961794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UNC93B1 variants underlie TLR7-dependent autoimmunity.
    Wolf C; Lim EL; Mokhtari M; Kind B; Odainic A; Lara-Villacanas E; Koss S; Mages S; Menzel K; Engel K; Dückers G; Bernbeck B; Schneider DT; Siepermann K; Niehues T; Goetzke CC; Durek P; Minden K; Dörner T; Stittrich A; Szelinski F; Guerra GM; Massoud M; Bieringer M; de Oliveira Mann CC; Beltrán E; Kallinich T; Mashreghi MF; Schmidt SV; Latz E; Klughammer J; Majer O; Lee-Kirsch MA
    Sci Immunol; 2024 Feb; 9(92):eadi9769. PubMed ID: 38207055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers.
    Soni C; Wong EB; Domeier PP; Khan TN; Satoh T; Akira S; Rahman ZS
    J Immunol; 2014 Nov; 193(9):4400-14. PubMed ID: 25252960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.
    Nickerson KM; Christensen SR; Shupe J; Kashgarian M; Kim D; Elkon K; Shlomchik MJ
    J Immunol; 2010 Feb; 184(4):1840-8. PubMed ID: 20089701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro.
    Zou Z; Du D; Miao Y; Yang Y; Xie Y; Li Z; Zhou L; Zhang L; Zhou P; Jiang F
    Int Immunopharmacol; 2020 Aug; 85():106648. PubMed ID: 32504998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
    Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
    Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.